GMP Consulting FAQ — Your Questions Answered

Everything you need to know about GMP compliance, FDA regulations, working with a consultant, and preparing for inspections. Get clear, expert answers backed by real-world experience with 200+ manufacturers.

GMP Basics

Foundational questions about Good Manufacturing Practice regulations, who they apply to, and why compliance matters for FDA-regulated manufacturers.

GMP stands for Good Manufacturing Practice — a set of regulations enforced by the FDA that govern how products are manufactured, processed, packed, and held. GMP regulations exist to protect consumers by ensuring products are consistently produced and controlled according to quality standards.

For manufacturers of pharmaceuticals, dietary supplements, cosmetics, and food products, GMP compliance is not optional — it is a legal requirement under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Non-compliance can result in FDA warning letters (Form 483 observations), product seizures, injunctions, import alerts, facility shutdowns, and criminal prosecution.

Beyond regulatory risk, GMP compliance protects your brand reputation, reduces product recalls, and builds consumer trust. The FDA conducts routine inspections of registered facilities, and a failed inspection can cost a company millions in remediation, lost production, and legal fees.

Understanding GMP is the first step toward building a quality-driven manufacturing operation. Learn more about how we help companies prepare for FDA scrutiny in our FDA inspection preparation service.

GMP (Good Manufacturing Practice) and cGMP (current Good Manufacturing Practice) refer to the same set of FDA regulations. The "c" in cGMP stands for "current," and the FDA uses this term to emphasize that manufacturers must use up-to-date systems, technologies, and scientific approaches rather than relying on outdated practices.

What was considered state-of-the-art in manufacturing quality ten or twenty years ago may no longer meet today's expectations. For example, the FDA expects modern environmental monitoring programs, validated computerized systems, and risk-based approaches to quality management.

The key regulations — 21 CFR Parts 210/211 for pharmaceuticals, 21 CFR Part 111 for dietary supplements, 21 CFR Part 117 for food, and ISO 22716 for cosmetics — all carry this "current" expectation.

When FDA investigators inspect your facility, they evaluate not just whether you follow the written regulations, but whether your methods reflect current industry best practices and available technology. Our GMP certification guide explains these requirements in detail.

Any company that manufactures, processes, packs, or holds FDA-regulated products must follow applicable GMP regulations. This includes:

  • Pharmaceutical manufacturers — 21 CFR Parts 210 and 211
  • Dietary supplement manufacturers, packers, labelers, and holders — 21 CFR Part 111
  • Food manufacturers and processors — 21 CFR Part 117 under FSMA
  • Cosmetics manufacturers — ISO 22716, now mandatory under MoCRA as of 2023
  • OTC drug manufacturers — 21 CFR Parts 210 and 211
  • Medical device manufacturers — 21 CFR Part 820
  • Contract manufacturers, co-packers, and third-party testing laboratories

The requirement applies regardless of company size. Even small supplement brands that outsource manufacturing to a contract manufacturer (CMO) are responsible for ensuring their CMO follows GMP regulations.

Foreign manufacturers exporting to the United States must also comply with U.S. GMP requirements and are subject to FDA inspection. Contact us if you are unsure which regulations apply to your operation.

Different industries are governed by different sections of Title 21 of the Code of Federal Regulations (CFR). Here is a breakdown of the primary GMP regulations by industry:

  • Pharmaceutical and OTC drug manufacturers must comply with 21 CFR Parts 210 (Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General) and 211 (Current Good Manufacturing Practice for Finished Pharmaceuticals).
  • Dietary supplement manufacturers follow 21 CFR Part 111 (Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements).
  • Food manufacturers must comply with 21 CFR Part 117 (Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food) under the Food Safety Modernization Act (FSMA).
  • Cosmetics manufacturers now follow ISO 22716 as required by the Modernization of Cosmetics Regulation Act (MoCRA) of 2022, which took effect in 2023.
  • Medical device manufacturers follow 21 CFR Part 820 (Quality System Regulation).

Each regulation has specific requirements for personnel, facilities, equipment, production controls, quality control, documentation, and complaint handling. Our GMP certification guide provides a detailed comparison across industries.

Working with a GMP Consultant

What to expect when engaging a GMP consultant, including costs, credentials, and how to evaluate the right fit for your manufacturing operation.

A GMP consultant helps manufacturers achieve, maintain, and improve compliance with Good Manufacturing Practice regulations. Core services typically include:

  • Conducting gap analyses to identify where current operations fall short of regulatory requirements
  • Developing and implementing quality management systems (QMS)
  • Writing standard operating procedures (SOPs), batch production records, and specifications
  • Designing and delivering employee training programs
  • Performing mock FDA inspections to prepare your facility for the real thing
  • Remediating FDA 483 observations and drafting warning letter responses
  • Validating processes, cleaning procedures, and analytical methods
  • Establishing CAPA (Corrective and Preventive Action) systems

A qualified GMP consultant brings industry-specific expertise that most companies cannot maintain in-house. Rather than hiring a full-time quality director — which can cost $150,000 to $250,000 annually — many small and mid-sized manufacturers engage a consultant to build their compliance systems and train their teams to maintain them independently.

Learn more about our specific service offerings for dietary supplements, OTC drugs, cosmetics, and food manufacturing.

GMP consulting costs vary significantly based on your industry, facility size, product complexity, and current compliance status. Here are typical investment ranges:

To put these costs in perspective: a single FDA warning letter can cost a company $500,000 to several million dollars in remediation, legal fees, lost production, and reputational damage. A product recall averages $10 million in direct costs. The investment in proactive GMP consulting is a fraction of the cost of non-compliance.

Contact us for a custom quote based on your specific situation.

Choosing the right GMP consultant requires evaluating several critical factors:

1. Industry-specific experience. A consultant who specializes in pharmaceutical GMP (21 CFR 210/211) may not have deep expertise in supplement GMP (21 CFR 111), and vice versa. Ask for case studies and references from companies in your specific industry.

2. Credentials and certifications. Look for recognized certifications like the CPGP (Certified Pharmaceutical GMP Professional) from ASQ, CFSQA (Certified Food Safety and Quality Auditor), RAC (Regulatory Affairs Certification) from RAPS, and relevant degrees in quality management, regulatory affairs, or law.

3. Approach to independence. The best consultants build systems your team can maintain independently, not ones that create dependency on ongoing consulting fees.

4. FDA inspection track record. Ask about their clients' audit pass rates and whether they have experience responding to 483 observations and warning letters.

5. Business acumen. Look for a consultant who understands the business side of compliance — someone who can prioritize risks and implement solutions efficiently without over-engineering systems that slow down your operations.

Learn about our qualifications and why 200+ manufacturers trust The GMP Consultant.

The most relevant credentials for a GMP consultant depend on your industry, but several certifications signal genuine expertise:

  • CPGP (Certified Pharmaceutical GMP Professional) from ASQ — the gold standard for pharmaceutical and supplement GMP consulting. Requires demonstrated knowledge of FDA regulations, quality systems, and manufacturing controls.
  • CMQ-OE (Certified Manager of Quality/Organizational Excellence) from ASQ — demonstrates broad quality management competence.
  • CFSQA (Certified Food Safety & Quality Auditor) from ASQ — essential for food and supplement GMP consulting.
  • RAC (Regulatory Affairs Certification) from RAPS — indicates deep regulatory knowledge across FDA-regulated industries.
  • PMP (Project Management Professional) — valuable because GMP implementation projects require disciplined project management.

Advanced degrees in relevant fields add significant value — particularly a JD (law degree) for understanding the legal framework of FDA regulations, or an MBA for understanding the business impact of compliance decisions.

Be cautious of consultants who lack recognized certifications or who cannot demonstrate a track record with specific, verifiable client outcomes. See Jared Clark's credentials — JD, MBA, PMP, CMQ-OE, CPGP, CFSQA, and RAC certified.

GMP Compliance Process

Understand the practical steps involved in achieving GMP compliance — from initial assessment through documentation development to FDA inspection readiness.

The timeline to achieve GMP compliance depends on your starting point, industry, and the resources you dedicate to the project. Here are typical timelines by industry:

Key factors that affect the timeline include facility condition and layout, number of products and SKUs, existing documentation and SOPs, staff availability for training and implementation, whether process validation is required, and the complexity of your supply chain.

Working with an experienced GMP consultant can significantly reduce these timelines by providing proven templates, efficient implementation strategies, and expert guidance that avoids common pitfalls. Schedule a free consultation to discuss your timeline.

A GMP gap analysis is a systematic assessment that compares your current manufacturing operations, quality systems, and documentation against the applicable FDA regulations to identify areas of non-compliance — the "gaps." It is typically the first step in any GMP consulting engagement.

During a gap analysis, a consultant evaluates:

  • Facility design and maintenance
  • Equipment calibration and maintenance programs
  • Raw material and component controls
  • Production and process controls
  • Packaging and labeling operations
  • Quality control laboratory operations
  • Documentation and record-keeping systems
  • Personnel qualifications and training programs
  • Cleaning and sanitation procedures
  • Complaint handling and CAPA systems
  • Supplier qualification programs

The deliverable is a detailed gap analysis report that prioritizes findings by risk level — critical, major, and minor — with specific recommendations for remediation. Critical gaps are those that could result in immediate regulatory action or product safety issues.

A well-executed gap analysis provides the roadmap for your entire GMP compliance project, allowing you to allocate resources efficiently and address the highest-risk areas first. Request a gap analysis for your facility.

GMP compliance requires a comprehensive documentation system that creates a complete record of how products are manufactured and controlled. The core documents include:

  • Quality Manual — defines your quality management system and organizational structure
  • Standard Operating Procedures (SOPs) — for every critical operation, from receiving raw materials through manufacturing, packaging, testing, storage, and distribution
  • Master Batch Records — define the complete manufacturing instructions for each product
  • Batch Production Records — document the actual execution of each production run
  • Specifications — raw material, component, and finished product specifications with acceptance criteria
  • Cleaning and Sanitation SOPs and records
  • Equipment Calibration and Maintenance logs
  • Training Records — documenting employee qualifications and ongoing training
  • Complaint Handling procedures and investigation records
  • CAPA (Corrective and Preventive Action) procedures and documentation
  • Supplier Qualification records
  • Stability Testing protocols and data
  • Change Control procedures

The specific requirements vary by regulation — 21 CFR Part 111 for supplements, Parts 210/211 for pharmaceuticals, Part 117 for food — but the principle is the same: if it is not documented, it did not happen.

Every batch, every deviation, every corrective action must be recorded, reviewed, and retained. Our GMP certification guide breaks down the documentation requirements by industry.

An FDA GMP inspection typically begins with an unannounced visit from one or more FDA investigators who present their credentials and a Notice of Inspection (Form 482). The inspection process includes:

  • Opening meeting — investigators explain the scope and purpose of the inspection
  • Facility walkthrough — covering all manufacturing, packaging, testing, and storage areas
  • Documentation review — batch records, SOPs, training records, complaint files, CAPA logs, and quality control testing data
  • Employee interviews — at all levels from production floor workers to quality management
  • Observation of operations — watching actual manufacturing processes in progress

The inspection typically lasts 2 to 5 days for dietary supplement manufacturers and may extend to 1 to 3 weeks for pharmaceutical facilities.

At the conclusion, FDA investigators hold a closeout meeting and present any deficiencies on FDA Form 483 (Inspectional Observations). You have 15 business days to respond in writing with your corrective action plan. If deficiencies are serious or systemic, the FDA may escalate to a Warning Letter, import alert, consent decree, or even criminal prosecution.

This is why FDA inspection preparation — including mock inspections with a qualified GMP consultant — is critical. Our clients maintain a 100% first-time audit pass rate because we prepare them thoroughly before FDA arrives.

Industry-Specific GMP Questions

Detailed answers about GMP requirements for specific industries — dietary supplements, cosmetics under MoCRA, and how pharmaceutical GMP standards compare.

21 CFR Part 111 establishes the current Good Manufacturing Practice requirements specifically for dietary supplement manufacturers, packers, labelers, and holders. The regulation is organized into subparts covering every aspect of supplement manufacturing:

  • Subpart B — Personnel: Requires qualified personnel with education, training, and experience to perform their assigned functions, plus a quality control unit with authority to approve or reject materials and products
  • Subpart C — Physical Plant and Grounds: Facilities must be designed to prevent contamination, with adequate space, lighting, ventilation, and pest control
  • Subpart D — Equipment and Utensils: Requires calibrated, maintained equipment of appropriate design and material
  • Subpart E — Master Manufacturing Record and Batch Production Record requirements
  • Subpart F — Production and Process Controls: Including identity testing of all incoming components (100% identity testing is mandatory), in-process controls, and specifications
  • Subpart G — Packaging and Labeling
  • Subpart H — Holding and Distribution
  • Subparts I through L — Returned Products, Product Complaints, Laboratory Operations, and Quality Control procedures

One of the most commonly cited violations is the failure to verify the identity of all dietary ingredients through testing — the FDA requires identity testing of every incoming lot, not just certificates of analysis from suppliers.

Our dietary supplement consulting service addresses every subpart of 21 CFR 111 with proven implementation frameworks.

The Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022 as part of the Consolidated Appropriations Act of 2023, represents the most significant expansion of FDA authority over cosmetics since 1938. MoCRA introduced several mandatory requirements:

  • Facility Registration — all facilities that manufacture or process cosmetics for U.S. distribution must register with the FDA and renew biennially
  • Product Listing — companies must list each cosmetic product with the FDA, including ingredients
  • Good Manufacturing Practices — based on ISO 22716 (Cosmetics — Good Manufacturing Practices), now mandatory, not voluntary
  • Serious Adverse Event Reporting — companies must report serious adverse events to the FDA within 15 business days
  • Safety Substantiation — manufacturers must ensure and maintain records supporting the safety of their cosmetic products
  • Labeling Requirements — now include fragrance allergen disclosure on product labels

For cosmetics manufacturers who previously operated with minimal FDA oversight, MoCRA requires significant investment in quality systems, documentation, and compliance infrastructure.

Companies that also manufacture dietary supplements or OTC drugs may be able to leverage existing GMP systems, but the ISO 22716 standard has specific requirements unique to cosmetics manufacturing.

Learn more about our cosmetics MoCRA compliance consulting services.

While both pharmaceutical GMP (21 CFR Parts 210/211) and dietary supplement GMP (21 CFR Part 111) share the same fundamental goal of ensuring product quality and safety, pharmaceutical GMP requirements are significantly more stringent in several key areas:

  • Process Validation is required for pharmaceutical manufacturing — you must demonstrate through documented evidence that your manufacturing process consistently produces a product meeting predetermined specifications. 21 CFR Part 111 does not explicitly require traditional process validation, though process controls are mandatory.
  • Stability Testing for pharmaceuticals must follow formal ICH guidelines with defined storage conditions, time points, and statistical analysis to establish expiration dating. Supplement GMP does not mandate formal stability programs, though they are best practice.
  • Analytical Testing requirements are more extensive for pharmaceuticals — every batch typically requires full identity, strength, purity, and quality testing. Supplement GMP requires identity testing of all components and appropriate finished product testing, but protocols are generally less complex.
  • Equipment Qualification for pharmaceutical manufacturing includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols.
  • Cleaning Validation with scientifically justified acceptance criteria and residue limits is required for pharmaceutical operations.
  • Change Control under pharmaceutical GMP requires formal impact assessments and regulatory filings for certain changes.

For companies manufacturing both supplements and pharmaceuticals, the pharmaceutical GMP standard typically serves as the baseline, with supplement-specific requirements layered in where applicable. Our GMP certification guide provides a detailed side-by-side comparison.

Still Have Questions?

Schedule a free consultation with Jared Clark, CPGP, CFSQA, RAC. We'll answer your specific GMP questions, assess your compliance needs, and outline a clear path forward.